Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Cogentin
Benztropine is an anticholinergic medication primarily used to treat the symptoms of Parkinson's disease and other movement disorders caused by certain medications. It belongs to a class of drugs called antimuscarinics, which work by blocking the action of acetylcholine, a neurotransmitter that plays a role in muscle control and other bodily functions. Benztropine helps to reduce tremors, muscle rigidity, and slow movement. It can also be used to treat dystonia, a condition characterized by involuntary muscle contractions and spasms.
For treating symptoms of Parkinson's disease and drug-induced movement disorders.
Outcome:
Increased anticholinergic effects (e.g., confusion, hallucinations, dry mouth, constipation)
Mechanism:
Additive anticholinergic effects
Outcome:
May increase dyskinesias
Mechanism:
Complex interaction
Outcome:
Decreased absorption of benztropine
Mechanism:
Altered gastric pH
Most likely new formulation: Extended-release formulation (Year 2025, 70% confidence)
Based on current usage trends and safety profile, benztropine is expected to maintain its current regulatory status with a 95% likelihood over the next 5 years.
Anticholinergic, Antimuscarinic
Diphenylmethane derivative